Black Swift Group’s Bristol-Myers Squibb BMY Stock Holding History

Black Swift Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$936K	Sell	16,250 -1,200	-7%	-$68.9K	0.14%	83
2026 Q1	$1.06M	Sell	17,450 -17,500	-50%	-$1.02M	0.19%	77
2025 Q4	$1.89M	Buy	+34,950	New	+$1.68M	0.31%	55
2021 Q2	–	Sell	-791	Closed	-$50K	–	93
2021 Q1	$50K	Hold	791	–	–	0.02%	110
2020 Q4	$49K	Hold	791	–	–	0.03%	90
2020 Q3	$48K	Sell	791 -1,000	-56%	-$60.2K	0.02%	75
2020 Q2	$105K	Hold	1,791	–	–	0.08%	60
2020 Q1	$100K	Buy	+1,791	New	+$109K	0.1%	44

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Black Swift Group's BMY Position: Q2 2026 in Review

Black Swift Group reduced its Bristol-Myers Squibb (BMY) stake by 6.9% in Q2 2026, selling an estimated $68.9K and leaving 16,250 shares worth $936K. The position accounts for 0.14% of the portfolio, ranked #83.

Black Swift Group first reported a position in BMY in Q1 2020 and has held it in 8 quarters since. The position peaked at $1.89M in Q4 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Black Swift Group held 16,250 shares of Bristol-Myers Squibb worth $936K as of Q2 2026.
Black Swift Group sold 1,200 Bristol-Myers Squibb shares in Q2 2026, an estimated $68.9K.
Bristol-Myers Squibb made up 0.14% of Black Swift Group's portfolio in Q2 2026, its #83 holding.
Black Swift Group first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 8 quarters since.
Black Swift Group's Bristol-Myers Squibb position peaked at $1.89M in Q4 2025.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Black Swift Group's 13F filing for Q2 2026, filed 13 Aug 2026.